Companies who receive scientific advice from our NICE Advice service may experience a faster path to guidance publication, a study has found. The research, which will be presented to delegates at the ...

Are you facing challenges in quickly bringing new healthtech products to market? The NHS is a large and complex system and ...

We use tools such as Google Analytics, Hotjar, Google Optimize and Loop11 to help us anonymously measure how you use our websites. This allows us to make improvements based on our users' needs.

The London School of Economics and Political Science (LSE) have joined forces with NICE to offer a unique solution - the Executive MSc in Healthcare Decision-Making.

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Suggested remit: To appraise the clinical and cost effectiveness of darolutamide with androgen deprivation therapy within its marketing authorisation for treating hormone-sensitive metastatic prostate ...

We have also today published a new discussion aid to support shared decision making about HRT, focusing on the key risks and benefits to consider. The guideline clarifies that whilst HRT has some ...

A list of downloadable documents created during development.

To find NICE guidance on related topics, including guidance in development, see the NICE topic page on menopause. For full details of the evidence and the guideline committee's discussions, see the ...

The November 2024 version of NICE's guideline on menopause updates and replaces the previous version published in November 2015. New evidence reviewed included information on endometrial cancer, ...

Your organisation needs to be registered as a stakeholder before we can accept comments. Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your ...